feed,title,long_url,short_url
Benzinga,KP Tissue declares a Quarterly Dividend of $0.18 per Common Share,https://www.benzinga.com/pressreleases/20/08/g16962044/kp-tissue-declares-a-quarterly-dividend-of-0-18-per-common-share,https://j.mp/2C8KCi4
Benzinga,Norwegian Cruise Line Holdings Reports Second Quarter 2020 Financial Results,https://www.benzinga.com/pressreleases/20/08/g16961997/norwegian-cruise-line-holdings-reports-second-quarter-2020-financial-results,https://j.mp/3a2GeO3
Benzinga,"Laureate Education Reports Second Quarter and Six Months Ended June 30, 2020 Financial Results",https://www.benzinga.com/pressreleases/20/08/g16961974/laureate-education-reports-second-quarter-and-six-months-ended-june-30-2020-financial-results,https://j.mp/2DBqu8G
Benzinga,Orchard Therapeutics Advances New Strategic Plan and Reports Second Quarter 2020 Financial Results,https://www.benzinga.com/pressreleases/20/08/g16961968/orchard-therapeutics-advances-new-strategic-plan-and-reports-second-quarter-2020-financial-results,https://j.mp/2DjIkxc
Benzinga,"Agios to Present at the Virtual Canaccord 40th Annual Growth Conference on Thursday, August 13, 2020",https://www.benzinga.com/pressreleases/20/08/g16961959/agios-to-present-at-the-virtual-canaccord-40th-annual-growth-conference-on-thursday-august-13-2020,https://j.mp/33Kpev1
Benzinga,Codexis Adds Dr. Jennifer L. Aaker to its Board of Directors,https://www.benzinga.com/pressreleases/20/08/g16961955/codexis-adds-dr-jennifer-l-aaker-to-its-board-of-directors,https://j.mp/39Z5BQG
Benzinga,BioXcel Therapeutics to Participate in the Canaccord Genuity 40th Annual Growth Conference,https://www.benzinga.com/pressreleases/20/08/g16961952/bioxcel-therapeutics-to-participate-in-the-canaccord-genuity-40th-annual-growth-conference,https://j.mp/3fAZROl
Benzinga,Checkster Brings Candidate Screening Insights to HCI Webcast,https://www.benzinga.com/pressreleases/20/08/g16961944/checkster-brings-candidate-screening-insights-to-hci-webcast,https://j.mp/2Xy5J4N
Benzinga,Menlo Reports Second Quarter 2020 Financial Results and Provides Business Update,https://www.benzinga.com/pressreleases/20/08/g16961926/menlo-reports-second-quarter-2020-financial-results-and-provides-business-update,https://j.mp/3kfUpnz
Benzinga,Antares Pharma Reports Strong Second Quarter 2020 Operating and Financial Results; Reinstates Full-Year 2020 Revenue Guidance,https://www.benzinga.com/pressreleases/20/08/g16961912/antares-pharma-reports-strong-second-quarter-2020-operating-and-financial-results-reinstates-full-,https://j.mp/33wn7up
Benzinga,Onex Reports Second-Quarter 2020 Results,https://www.benzinga.com/pressreleases/20/08/g16961911/onex-reports-second-quarter-2020-results,https://j.mp/33xEWcL
Benzinga,"Calibre Mining Q2 2020 and Multi-Year Outlook Conference Call and Webcast on August 11, 2020",https://www.benzinga.com/pressreleases/20/08/g16961908/calibre-mining-q2-2020-and-multi-year-outlook-conference-call-and-webcast-on-august-11-2020,https://j.mp/2DJzmJ9
Benzinga,Athenex Announces $50 Million Revenue Interest Financing with Sagard Healthcare Royalty Partners,https://www.benzinga.com/pressreleases/20/08/g16961902/athenex-announces-50-million-revenue-interest-financing-with-sagard-healthcare-royalty-partners,https://j.mp/2Xy5HtH
Benzinga,Fulcrum Therapeutics to Participate in Upcoming Investor Conferences,https://www.benzinga.com/pressreleases/20/08/g16961900/fulcrum-therapeutics-to-participate-in-upcoming-investor-conferences,https://j.mp/2C2hs3W
Benzinga,"Recro to Report Second Quarter 2020 Financial Results and Host Conference Call and Webcast on August 10, 2020",https://www.benzinga.com/pressreleases/20/08/g16961897/recro-to-report-second-quarter-2020-financial-results-and-host-conference-call-and-webcast-on-augu,https://j.mp/3ibb35W
